) -- Shares of

Biostar Pharmaceuticals



) have taken a tremendous swing upward. The stock is trading at $2.97 as of 10:07 a.m. ET, 33.8% above Thursday's closing price of $2.22. Volume is at 3.9 million, 26.1 times the daily average of 150,700.

Biostar has a market cap of $59.7 million and is part of the

health care

sector and


industry. Shares are down 22.3% year to date as of the close of trading on Thursday.

Biostar Pharmaceuticals, Inc., through its subsidiary, Shaanxi Biostar Biotech, Ltd., discovers, develops, manufactures, and markets over-the-counter and prescription pharmaceutical products, and nutrient products for various diseases and conditions in the People's Republic of China. The company has a P/E ratio of 6.2, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 16.

TheStreet Ratings rates Biostar as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and increase in net income. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year. You can view the full

Biostar Ratings Report


See our

top % gaining stocks list

for other stocks that are soaring today, or get investment ideas from our

investment research center


Interested in other stocks that are soaring? Get free SMS text alerts sent to you when the action happens by texting


to 95370 or select from

multiple alert options